Literature DB >> 8386882

Identification and characterization of glycoprotein gH of human herpesvirus-6.

G Qian1, C Wood, B Chandran.   

Abstract

Sequence analysis of an 8-kb BamHI-G DNA fragment from human herpesvirus-6 variant A strain GS (HHV-6A(GS)) has identified a gene encoding a glycoprotein homologous to glycoprotein gH of other herpesviruses and this gene was designated as HHV-6 gH (Josephs et al., J. Virol. 65, 5597). The open reading frame (ORF) of HHV-6A(GS) gH gene was amplified by polymerase chain reaction and was expressed as a trpE fusion protein in bacteria. Stable fusion protein was made only with constructs containing amino acids 15 to 469 of the ORF and this fusion protein was used to raise rabbit antisera. In the in vitro transcription-translation analysis of the gH gene, addition of microsomal membranes resulted in the processing of an unprocessed precursor to a polypeptide product of about 108 K. These in vitro-synthesized precursor and product forms were immunoprecipitated by the rabbit antibodies against the gH fusion protein. Rabbit anti-gH antibodies neutralized the infectivity of both HHV-6 variant A strain GS and variant B strain Z-29, and immunoprecipitation reactions identified a virion envelope-associated 102 K polypeptide as the glycoprotein gH of HHV-6 variants A and B. In addition to the 102 K glycoprotein, nonglycosylated polypeptides of about 58 and 164 K with different partial peptide maps were also consistently coimmunoprecipitated from [35S]methionine-labeled HHV-6A(GS)-infected cells, but not from HHV-6B(Z-29)-infected cells. The similarity in the molecular weights of glycoprotein gH among the two strains belonging to the two variant groups of HHV-6 and neutralization of infectivity of both groups by rabbit antibodies against HHV-6A(GS) gH suggests conserved functions of glycoprotein gH among the two variant groups of HHV-6.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386882     DOI: 10.1006/viro.1993.1272

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Herpesvirus 6 glycoproteins B (gB), gH, gL, and gQ are necessary and sufficient for cell-to-cell fusion.

Authors:  Yuki Tanaka; Tadahiro Suenaga; Misako Matsumoto; Tsukasa Seya; Hisashi Arase
Journal:  J Virol       Date:  2013-07-24       Impact factor: 5.103

2.  Human herpesvirus 6 variant A glycoprotein H-glycoprotein L-glycoprotein Q complex associates with human CD46.

Authors:  Yasuko Mori; Xuwei Yang; Pilailuk Akkapaiboon; Toshiomi Okuno; Koichi Yamanishi
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

3.  Determination and analysis of the complete nucleotide sequence of human herpesvirus.

Authors:  J Nicholas
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

4.  Characterization of transcripts expressed from human herpesvirus 6A strain GS immediate-early region B U16-U17 open reading frames.

Authors:  L M Flebbe-Rehwaldt; C Wood; B Chandran
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 5.  Immune response to HHV-6 and implications for immunotherapy.

Authors:  Aniuska Becerra; Laura Gibson; Lawrence J Stern; J Mauricio Calvo-Calle
Journal:  Curr Opin Virol       Date:  2014-10-27       Impact factor: 7.090

6.  Discovery of a second form of tripartite complex containing gH-gL of human herpesvirus 6 and observations on CD46.

Authors:  Yasuko Mori; Pilailuk Akkapaiboon; Sayoko Yonemoto; Masato Koike; Masaya Takemoto; Tomohiko Sadaoka; Yumi Sasamoto; Shozo Konishi; Yasuo Uchiyama; Koichi Yamanishi
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  The human herpesvirus 6 U100 gene product is the third component of the gH-gL glycoprotein complex on the viral envelope.

Authors:  Yasuko Mori; Pilailuk Akkapaiboon; Xuwei Yang; Koichi Yamanishi
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

8.  Identification and characterization of a cDNA derived from multiple splicing that encodes envelope glycoprotein gp105 of human herpesvirus 6.

Authors:  B Pfeiffer; B Thomson; B Chandran
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.